Session date: 
11/14/2018 - 12:00pm to 1:00pm

Sahil Khanna, MBBS
Associate Professor, Gastroenterology and Hepatology


Locations:

  • Geffen Auditorium (Live)
  • Broadcast to SMH Alfred M-459 and BA 4-316/BA 4-516
  • Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis

Learning Objectives:

  • Discuss updates in Epidemiology of primary and recurrent Clostridium difficile infection
  • Review updates in testing for Clostridium difficile infection including PCR and other tests
  • Explain drug treatment for primary and recurrent Clostridium difficile infection
  • Describe advances in microbial replacement for recurrent Clostridium difficile infection

Financial Disclosures:
Grant/Research Support - Rebiotix

Off Label/Investigational uses:
Fecal microbiota transplantation and Metronidazole (C. difficile infection treatment)

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Presenter: 
Sahil Khanna, MBBS
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota